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The relationship between maternal gluten intake in pregnancy, offspring intake in childhood,
and offspring risk of type 1 diabetes has not been examined jointly in any studies. Our aim
was to study the relationship between maternal and child intake of gluten and risk of type 1
diabetes in children.
Methods and findings
We included 86,306 children in an observational nationwide cohort study, the Norwegian
Mother and Child Cohort Study (MoBa), with recruitment from 1999 to 2008 and with follow-
up time to April 15, 2018. We used registration of type 1 diabetes in the Norwegian childhood
diabetes registry as the outcome. We used Cox proportional hazard regression to estimate
hazard ratios (HRs) for the mother’s intake of gluten up to week 22 of pregnancy and off-
spring gluten intake when the child was 18 months old. The average time followed was 12.3
years (0.70–16.0). A total of 346 children (0.4%) children were diagnosed with type 1 diabe-
tes, resulting in an incidence rate of 32.6/100,000 person-years. Mean gluten intake per day
was 13.6 g for mothers and 8.8 g for children. There was no association between the moth-
er’s intake of gluten in pregnancy and offspring type 1 diabetes, with an adjusted HR (aHR)
of 1.02 (95% confidence interval [CI] 0.73–1.43, p = 0.91) for each 10-g-per-day increment.
There was an association between offspring intake of gluten and a higher risk of type 1 dia-
betes, with an aHR of 1.46 (95% CI 1.06–2.01, p = 0.02) for each 10-g-per-day increment.
Among the limitations are the likely imprecision in estimation of gluten intake and that we
only had information regarding gluten intake at 2 time points in early life.
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Conclusions
Our results show that, while the mother’s intake of gluten in pregnancy was not associated
with type 1 diabetes, a higher intake of gluten by the child at an early age may give a higher
risk of type 1 diabetes.
Author summary
Why was this study done?
• Results from another large Nordic cohort showed that the mother’s intake of gluten in
pregnancy was associated with offspring risk of type 1 diabetes, but the study did not
have information on the child’s diet.
• To our knowledge, the relationship between maternal gluten intake in pregnancy, off-
spring intake in childhood, and risk of type 1 diabetes has not been examined jointly in
any studies.
What did the researchers do and find?
• We studied the relationship between maternal and offspring intake of gluten and risk of
type 1 diabetes in children from a Norwegian observational nationwide cohort study
with recruitment during the period from 1999 to 2008 including more than 80,000
children.
• There was an association between the child’s intake of gluten and a higher risk of type 1
diabetes in the child, but not between maternal intake and risk.
What do these findings mean?
• Our results show that, while the mother’s intake of gluten in pregnancy is not associated
with type 1 diabetes, a higher gluten intake by the child at an early age may give a higher
risk.
• These findings may motivate further research in the field, ideally a randomised con-
trolled trial (RCT).
Introduction
Type 1 diabetes is an increasingly common disease often presenting in childhood, with some
of the highest incidence rates in the Nordic countries [1]. Type 1 diabetes occurs after an
immune-mediated destruction of pancreatic beta cells, which in the end leads to lifelong
dependence on insulin treatment [2]. While genetic factors are important in the aetiology of
the disease, increased incidence rates over recent decades suggest a role for nongenetic factors
[1].
Gluten intake and type 1 diabetes
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Gluten has been hypothesised to be one of the environmental factors involved in the devel-
opment of type 1 diabetes [3]. It has been found in animal models and in vitro studies that glu-
ten may have an effect on the immune system by increasing proinflammatory cytokine
production or may lead to dysbiosis of the gut microbiota [3].
Most of the prospective studies in humans that have examined aspects of gluten intake as a
risk factor for type 1 diabetes have focused on age at introduction of cereals or gluten-contain-
ing foods in infancy in high-risk cohorts, with inconsistent results [4–11]. Two small studies
reported no association between maternal intake of gluten-containing foods in pregnancy and
development of islet autoimmunity [12, 13], but a recent, large cohort study found that the
mother’s intake of gluten while pregnant may increase the probability of the offspring having
type 1 diabetes [14]. The relationship between maternal gluten intake in pregnancy, the child’s
intake at 18 months, and the child’s risk of type 1 diabetes have not been examined together in
any studies.
The aim was to study the relationship between maternal and child intake of gluten and risk
of type 1 diabetes in children.
Methods
Participants and study design
We included participants in the Norwegian Mother and Child Cohort Study (MoBa) [15].
MoBa is a prospective nationwide, population-based pregnancy cohort in Norway during
1999–2009. The women consented to participation in 41% of the pregnancies. A total of
86,306 children, of whom 346 developed type 1 diabetes, were included in the analysis (Fig 1).
The current study is based on version VIII of the quality-assured data files. We used a pro-
spective analysis plan in designing the study (S1 Text). We used exposure information from
questionnaires (for English versions, see https://www.fhi.no/en/studies/moba/for-forskere-
artikler/questionnaires-from-moba) at pregnancy week 22 and offspring age 18 months. Data
were linked to the Medical Birth Registry of Norway and the Norwegian Patient Register using
personal identity numbers assigned to all Norwegian residents.
Exposures: Gluten intake during pregnancy and in the child at age 18
months
Intake of gluten was assessed from a semiquantitative food frequency questionnaire completed
around pregnancy week 22 and from a questionnaire at child’s age 18 months (S1 Fig). For the
food frequency questionnaire completed around pregnancy week 22, we derived the average
protein intake (grams per day) from gluten-containing flour or grains from the MoBa food
database. The food frequency questionnaire covered the period up to week 22 of pregnancy
and has been validated for food and nutrient intake [16]. To estimate the child’s gluten intake,
we used a questionnaire completed at 18 months covering the frequency of wheat-, rye-, and
barley-containing food intake. Portion sizes were obtained from a published report [17] and
product labels. We estimated the average protein intake (grams per day) from gluten-contain-
ing flour or grains by using recipes and nutritional contents of food items from the Norwegian
Food Composition Table [18] in addition to traditional recipes and ingredient lists from prod-
uct labels. The average gluten intake (grams per day) was estimated by using a conversion fac-
tor of 0.75 in accordance with most studies [19–21]. The conversion factor of 0.75 is based on
conversion factors of 0.80 for wheat, 0.65 for rye, and 0.50 for barley [21–23], wheat being the
most widely used grain in the different food products assessed.
Gluten intake and type 1 diabetes
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We excluded from the analyses children with a gluten intake above 35 g/day at 18 months
of age (n = 39, Fig 1). We categorised intake of gluten into percentiles (<10, 10–20, 20–50, 50–
80, 80–90, and�90) for comparison with the recently published study from Denmark [14].
Characteristics of participants are shown in Table 1. (Characteristics for participants with valid
information on intake of gluten in childhood are shown in S1 Table) Characteristics of partici-
pants excluded due to missing exposure data are shown in S2 Table.
Outcome: Type 1 diabetes
Time to clinical type 1 diabetes diagnosis in the child was used as the outcome. Data on off-
spring type 1 diabetes were obtained from the Norwegian Patient Registry and Norwegian
Childhood Diabetes Registry [24]. Nine cases of monogenic or type 2 diabetes were excluded
from the study. Identified during follow-up were a total of 346 children with type 1 diabetes
with valid information on maternal gluten intake at week 22 of pregnancy and 271 children
with valid information on child gluten intake at 18 months of age (Fig 1). Participants excluded
due to missing exposure information did not differ in their incidence of type 1 diabetes com-
pared to those included in the current analysis (S2 Fig).
Other variables
We obtained maternal age, parity, and mode of delivery and child sex, birth weight, and gesta-
tional age—categorised as shown in Table 1—from the Medical Birth Registry of Norway. The
MoBa recruitment questionnaire completed at week 18 of pregnancy provided data on mater-
nal education, smoking, prepregnant body mass index (BMI), maternal coeliac disease diagno-
sis, and maternal type 1 diabetes diagnosis. From MoBa questionnaires completed at child age
Fig 1. Flowchart of the study cohort. �The food frequency questionnaire was introduced in 2002 (response rate 92%). †In the analysis including both
pregnancy and childhood gluten intake, there were 62,900 participants with valid data (255 of these were type 1 diabetes cases). ‡Nine cases were
excluded from the analyses due to having the outcome of type 1 diabetes prior to the exposure measurement at 18 months. MoBa, Norwegian Mother
and Child Cohort Study.
https://doi.org/10.1371/journal.pmed.1003032.g001
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Table 1. Characteristics of the study participants included in the analysis of maternal gluten intake during pregnancy and risk of type 1 diabetes in the child.
Gluten intake by percentile All participants <10% 10%–20% 20%–50% 50%–80% 80%–90% >90%
Median (range) in g/day 13.0 (0–62.5) 5.9 (0–7.6) 8.7 (7.6–9.5) 11.4 (9.5–13.0) 14.8 (13.0–17.3) 18.4 (17.3–20.1) 23.0 (20.1–62.5)
Maternal characteristics n = 86,306 n = 8,518 n = 8,616 n = 25,962 n = 25,928 n = 8,653 n = 8,629
Age in years, mean (SD) 30.2 (4.6) 29.7 (4.9) 30.2 (4.6) 30.4 (4.5) 30.5 (4.4) 30.2 (4.5) 29.6 (4.9)
<25 9,165 (10.6) 1,293 (15.2) 965 (11.2) 2,422 (9.3) 2,267 (8.7) 924 (10.7) 1,294 (15.0)
25–34 61,812 (71.6) 5,818 (68.3) 6,091 (70.7) 18 797 (72.4) 18,844 (72.7) 6,254 (72.3) 6,008 (69.6)
�35 15,329 (17.8) 1,407 (16.5) 1,560 (18.1) 4,743 (18.3) 4,817 (18.6) 1,475 (17.0) 1,327 (15.4)
Prepregnancy BMI, mean (SD) 24.1 (4.3) 24.3 (4.5) 24.3 (4.4) 24.2 (4.3) 24.0 (4.2) 23.7 (4.1) 23.9 (4.4)
<20 10,522 (12.2) 1,068 (12.5) 945 (11.0) 2,954 (11.4) 3,133 (12.1) 1,208 (14.0) 1,214 (14.1)
20–25 47,032 (54.5) 4,307 (50.6) 4,672 (54.2) 14 182 (54.6) 14,388 (55.5) 4,838 (55.9) 4,645 (53.8)
25–29.9 18,475 (21.4) 1,936 (22.7) 1905 (22.1) 5,671 (21.8) 5,496 (21.2) 1,757 (20.3) 1,710 (19.8)
�30 8,055 (9.3) 916 (10.8) 896 (10.4) 2,500 (9.6) 2,289 (8.8) 646 (7.5) 808 (9.4)
Missing data 2,222 (2.6) 291 (3.4) 198 (2.3) 655 (2.5) 622 (2.4) 204 (2.4) 252 (2.9)
Prematurity 5,391 (6.2) 567 (6.7) 551 (6.4) 1,587 (6.1) 1,540 (5.9) 550 (6.4) 596 (6.9)
Missing data 61 (0.1) 6 (0.1) 7 (0.1) 22 (0.1) 16 (0.1) 3 (0.0) 7 (0.1)
Parity
0 39,548 (45.8) 4,561 (53.5) 4,196 (48.7) 11,744 (45.2) 11,201 (43.2) 3,858 (44.6) 3,988 (46.2)
1 30,447 (35.3) 2,667 (31.3) 2,885 (33.5) 9,339 (36.0) 9,561 (36.9) 3,085 (35.7) 2,910 (33.7)
�2 16,311 (18.9) 1,290 (15.1) 1,535 (17.8) 4,879 (18.8) 5,166 (19.9) 1,710 (19.8) 1,731 (20.1)
Smoking during pregnancy
No 78,332 (90.8) 7,570 (88.9) 7,780 (90.3) 23,814 (91.7) 23,769 (91.7) 7,858 (90.8) 7,541 (87.4)
Occasionally 1,465 (1.7) 154 (1.8) 163 (1.9) 427 (1.6) 404 (1.6) 159 (1.8) 158 (1.8)
Yes 6,044 (7.0) 745 (8.7) 619 (7.2) 1,586 (6.1) 1,615 (6.2) 602 (7.0) 877 (10.2)
Missing data 465 (0.5) 49 (0.6) 54 (0.6) 135 (0.5) 140 (0.5) 34 (0.4) 53 (0.6)
Maternal education
<12 years 31,116 (36.1) 3,864 (45.4) 3,331 (38.7) 8,858 (34.1) 8,247 (31.8) 3,006 (34.7) 3,810 (44.2)
12–15 years 34,982 (40.5) 2,909 (34.2) 3,408 (39.6) 10 854 (41.8) 11,128 (42.9) 3,537 (40.9) 3,146 (36.5)
�16 years 19,789 (22.9) 1,672 (19.6) 1,846 (21.4) 6,141 (23.7) 6,442 (24.8) 2,069 (23.9) 1,619 (18.8)
Missing data 419 (0.5) 73 (0.9) 31 (0.4) 109 (0.4) 111 (0.4) 41 (0.5) 54 (0.6)
Breastfeeding duration, mean (SD) 9.9 (4.5) 9.4 (4.6) 9.6 (4.6) 9.9 (4.5) 10.1 (4.5) 10.2 (4.5) 9.6 (4.6)
<6.0 months 12,701 (14.7) 1,424 (16.7) 1,395 (16.2) 3,825 (14.7) 3,525 (13.6) 1,139 (13.2) 1,393 (16.1)
6.0–11.9 months 26,226 (30.4) 2,453 (28.8) 2,596 (30.1) 8,136 (31.3) 7,969 (30.7) 2,630 (30.4) 2,442 (28.3)
�12 months 24,304 (28.2) 1981 (23.3) 2,270 (26.3) 7,433 (28.6) 7,802 (30.1) 2,580 (29.8) 2,238 (25.9)
Missing data 23,075 (26.7) 2,660 (31.2) 2,355 (27.3) 6,568 (25.3) 6,632 (25.6) 2,304 (26.6) 2,556 (29.6)
Fibre intake (g), mean (SD) 31.2 (11.9) 19.4 (8.1) 23.6 (7.7) 27.6 (7.1) 33.1 (7.9) 38.7 (9.0) 48.4 (16.7)
<20th centile 15,776 (18.3) 6,003 (70.5) 4,016 (46.6) 4,842 (18.7) 845 (3.3) 56 (0.6) 14 (0.2)
20–40th centile 16,719 (19.4) 1,318 (15.5) 2,431 (28.2) 8,432 (32.5) 4,098 (15.8) 360 (4.2) 80 (0.9)
40–60th centile 17,418 (20.2) 624 (7.3) 1,209 (14.0) 6,709 (25.8) 7,358 (28.4) 1,235 (14.3) 283 (3.3)
60–80th centile 17,931 (20.8) 325 (3.8) 633 (7.3) 4,201 (16.2) 8,328 (32.1) 3,099 (35.8) 1,345 (15.6)
80–100th centile 18,461 (21.4) 248 (2.9) 327 (3.8) 1,778 (6.8) 5,299 (20.4) 3,903 (45.1) 6,906 (80.0)
Missing data 1 (0.0) - - - - - 1 (0.0)
Energy intake (MJ), mean (SD) 9.8 (3.2) 6.9 (2.0) 7.9 (1.8) 8.9 (1.9) 10.3 (2.2) 11.6 (2.5) 14.1 (5.4)
<20th centile 15,744 (18.2) 5,699 (66.9) 3,701 (43.0) 5,060 (19.5) 1,205 (4.6) 70 (0.8) 9 (0.1)
20–40th centile 16,886 (19.6) 1,527 (17.9) 2,632 (30.5) 7,694 (29.6) 4,408 (17.0) 517 (6.0) 108 (1.3)
40–60th centile 17,420 (20.2) 703 (8.3) 1,309 (15.2) 6,636 (25.6) 6,833 (26.4) 1,468 (17.0) 471 (5.5)
60–80th centile 17,883 (20.7) 369 (4.3) 699 (8.1) 4,541 (17.5) 7,804 (30.1) 2,828 (32.7) 1,642 (19.0)
80–100th centile 18,372 (21.3) 220 (2.6) 275 (3.2) 2,031 (7.8) 5,678 (21.9) 3,770 (43.6) 6,398 (74.1)
Missing data 1 (0.0) - - - - - 1 (0.0)
Offspring characteristics
(Continued)
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6 and 18 months, we obtained information on breastfeeding duration and child age at the time
of gluten introduction [25]. MoBa age-7 or -8 questionnaires and register linkage to the Nor-
wegian Patient Register (to the end of 2016) provided information on the child’s coeliac dis-
ease diagnosis [26]. The Norwegian Patient Register also provided data on parents’ medical
codes indicative of coeliac disease and type 1 diabetes. We excluded children of mothers with
type 1 diabetes or coeliac disease due to the influence on the mother’s intake of gluten, and
potentially the child’s intake (n = 1,682; Fig 1).
Statistical analysis
Based on the previous Danish study [14] showing a relative risk of 2 comparing the upper and
lower categories of maternal gluten intake, we calculated that our sample size would provide
us with a statistical power of 94% for the analyses of maternal gluten intake and 88% for child’s
gluten intake.
We used Cox regression analysis to estimate hazard ratios (HRs) with 95% confidence
intervals (CIs). Follow-up time was counted from birth (when analysing mother’s gluten
intake) or from child’s age of 18 months (when analysing child’s gluten intake) to type 1 diabe-
tes diagnosis or end of follow-up (April 15, 2018). In analyses mutually adjusting for maternal
and child gluten intake, we started the follow-up at 18 months. We found no evidence for vio-
lation of the proportional hazards assumption by visually assessing log-minus log plots or for-
mally testing Schoenfeld residuals. We used robust cluster variance estimation to account for
potential correlation among siblings in the cohort. We predefined statistical significance as p-
values of 0.05 or 95% CIs for the HR not including 1.00. The primary analysis was further pre-
defined to be the test for linear trend (per 10-g increase in gluten intake per day), with
Table 1. (Continued)
Gluten intake by percentile All participants <10% 10%–20% 20%–50% 50%–80% 80%–90% >90%
Median (range) in g/day 13.0 (0–62.5) 5.9 (0–7.6) 8.7 (7.6–9.5) 11.4 (9.5–13.0) 14.8 (13.0–17.3) 18.4 (17.3–20.1) 23.0 (20.1–62.5)
Maternal characteristics n = 86,306 n = 8,518 n = 8,616 n = 25,962 n = 25,928 n = 8,653 n = 8,629
Cesarean section 13,001 (15.1) 1,450 (17.0) 1,401 (16.3) 3,863 (14.9) 3,730 (14.4) 1,225 (14.2) 1,332 (15.4)
Type 1 diabetes 346 (0.4) 23 (0.3) 45 (0.5) 102 (0.4) 99 (0.4) 42 (0.5) 35 (0.4)
Female 42,179 (48.9) 4,189 (49.2) 4,201 (48.8) 12,749 (49.1) 12,715 (49.0) 4,211 (48.7) 4,114 (47.7)
Birth weight (g), mean (SD) 3,561 (587) 3,514 (593) 3,539 (587) 3,561 (585) 3,580 (583) 3,571 (585) 3,557 (598)
<2,500 3,585 (4.2) 403 (4.7) 378 (4.4) 1,108 (4.3) 965 (3.7) 341 (3.9) 390 (4.5)
2,500–3,499 33,185 (38.5) 3,538 (41.5) 3,401 (39.5) 9,934 (38.3) 9,731 (37.5) 3,267 (37.8) 3,314 (38.4)
3,500–4,499 45,932 (53.2) 4,261 (50.0) 4,529 (52.6) 13,860 (53.4) 14,067 (54.3) 4,690 (54.2) 4,525 (52.4)
�4,500 3,598 (4.2) 315 (3.7) 308 (3.6) 1,058 (4.1) 1,162 (4.5) 355 (4.1) 400 (4.6)
Missing data 6 (0.0) 1 (0.0) - 2 (0.0) 3 (0.0) - -
Age at gluten introduction
<4.0 months 515 (0.6) 70 (0.8) 52 (0.6) 135 (0.5) 129 (0.5) 46 (0.5) 83 (1.0)
4.0–5.9 months 16,603 (19.2) 1,575 (18.5) 1,657 (19.2) 4,950 (19.1) 4,974 (19.2) 1,710 (19.8) 1,737 (20.1)
�6 months 59,347 (68.8) 5,614 (65.9) 5,883 (68.3) 18,193 (70.1) 18,061 (69.7) 5,935 (68.6) 5,661 (65.6)
Missing data 9,841 (11.4) 1,259 (14.8) 1,024 (11.9) 2,684 (10.3) 2,764 (10.7) 962 (11.1) 1,148 (13.3)
Coeliac disease diagnosis 828 (1.0) 70 (0.8) 84 (1.0) 253 (1.0) 269 (1.0) 83 (1.0) 69 (0.8)
Missing data 153 (0.2) 16 (0.2) 22 (0.3) 55 (0.2) 33 (0.1) 12 (0.1) 15 (0.2)
Weight gain (kg) 0–12 months, mean (SD) 6.4 (1.05) 6.4 (1.07) 6.4 (1.07) 6.4 (1.04) 6.4 (1.05) 6.3 (1.06) 6.4 (1.06)
Missing data 28,829 (33.4) 3,231 (37.9) 2,923 (33.9) 8,238 (31.7) 8,298 (32.0) 2,911 (33.6) 3,228 (37.4)
Abbreviation: BMI, body mass index
https://doi.org/10.1371/journal.pmed.1003032.t001
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covariates defined in model 2 (see subsequently), and to be based on a data set in which we
imputed missing covariates using multiple imputation with chained equations [27]. To test
nonlinearity, we analysed gluten as a categorical variable using the same cut-offs as the Danish
national prospective cohort study (Table 1 and S1 Table) [14].
In addition to unadjusted analyses, we decided a priori to adjust for variables that may be
associated with gluten intake and type 1 diabetes. Model 1 adjusted for covariates similar to
the Danish national prospective cohort study [14]: prepregnancy maternal BMI, age, parity,
smoking status, education, breastfeeding duration, cesarean section, energy intake, and child’s
sex. Model 2, our primary model, additionally adjusted for age at gluten introduction, birth
weight, prematurity, weight gain 0–12 months, and maternal fibre intake during pregnancy
and mutually adjusted maternal and child’s gluten intake. (In the mutually adjusted analyses,
maternal gluten intake is a potential confounder for the child’s gluten intake–type 1 diabetes
association, whereas child’s gluten intake is a potential mediator in the maternal gluten
intake–type 1 diabetes association.)
In sensitivity analyses to assess the impact of imputing missing covariates, we repeated the
main analyses in those with complete covariate data. In response to a peer review comment, we
made a Kaplan Meier survival plot of the main analyses stratified by child’s sex and birth weight,
and we made a density plot showing the distribution of maternal gluten intake in pregnancy and
child’s gluten intake at age 18 months. We also assessed the association of maternal fibre intake
and gluten intake from refined grains during pregnancy and risk of type 1 diabetes in the child.
Also, we assessed the impact of further adjusting our analyses for the child’s coeliac disease, and
we performed analyses after excluding children who were diagnosed with coeliac disease during
follow-up, as suggested in a peer review comment. In response to other peer review comments,
we did additional analyses including children who have a mother with type 1 diabetes or celiac
disease in the primary model, and we additionally adjusted for other types of diabetes in the
mother (type 2 diabetes or gestational diabetes obtained from the medical birth registry of Nor-
way) in the primary model. All analyses were done in Stata version 15 (College Station, TX).
Patient and public involvement
We conducted the study on previously collected data with no patient involvement in develop-
ment of the research question or outcome measures, nor in the development of design, the
recruitment, or the conduct of the study. Patients were not asked to advise on interpretation or
writing up of results. Results from MoBa are disseminated to study participants through press
releases, a yearly newsletter sent to all participating families, and the study’s and the Norwe-
gian Institute of Public Health’s websites.
Ethical approval
The establishment and data collection in MoBa was previously based on a licence from the
Norwegian Data Inspectorate and approval from the Regional Committee for Medical and
Health Research Ethics South East, and it is now based on regulations related to the Norwegian
Health Registry Act. All participants provided written informed consent. The present study
was approved by the Regional Committee for Medical and Health Research Ethics South East.
Results
Of all participating children, 0.4% were diagnosed with type 1 diabetes (n = 346) after a mean
of 12.3 years (range 0.7–16.0) of follow-up (Fig 1). The mean age at diagnosis was 7.5 years
(range 0.7–15.0). We had information on islet autoantibodies (towards insulin, glutamic acid
decarboxylase, and IA2) at diagnosis from 76% the children who developed type 1 diabetes,
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and 92% were positive for at least one islet autoantibody. The overall incidence rate of type 1
diabetes per 100,000 person-years was 32.6. Mean maternal gluten intake during pregnancy
was 13.6 g/day (standard deviation 5.2, median 13.0 g/day), and the child’s mean gluten intake
at age 18 months was 8.8 g/day (standard deviation 3.6, median 8.2 g/day). The distribution of
the mother’s intake of gluten and offspring intake of gluten in childhood is shown in S3 Fig.
Gluten intake was lower (p< 0.001) in mothers who had a lower fibre and energy intake
(Table 1). Gluten intake was also lower (p< 0.001) in children of mothers who were younger
and less educated and who breastfed their child for a shorter duration (S1 Table). Children of
mothers with a low gluten intake during pregnancy tended to have a lower gluten intake at 18
months, but the correlation was weak (Spearman’s rho = 0.11, p< 0.001, S4 Fig).
Maternal gluten intake during pregnancy and risk of type 1 diabetes in the
child
Maternal gluten intake during pregnancy was not associated with risk of type 1 diabetes in the
child (Table 2). For each 10-g/day-increase of gluten intake, the adjusted hazard ratio (aHR)
was 1.02 (95% CI 0.73–1.43, p = 0.91). For each standard deviation (5.2 g/day) increase of glu-
ten intake, the aHR was 1.01 (95% CI 0.85–1.20, p = 0.91). While there was a tendency towards
a nonlinear association—with higher risk of type 1 diabetes in those with the next lowest and
in those with the next highest category of maternal gluten intake—the global likelihood ratio
test did not support a significant nonlinear association (p = 0.11).
Gluten intake by the child at age 18 months and subsequent risk of type 1
diabetes
The child’s intake of gluten was significantly associated with higher risk of type 1 diabetes with
a dose-response relationship (Table 2). For each 10-g/day increase of gluten intake, the aHR
was 1.46 (95% CI 1.06–2.01, p = 0.02). For each standard deviation (3.6 g/day) increase of glu-
ten intake, the aHR was 1.15 (95% CI 1.02–1.29, p = 0.02).
While the child’s gluten intake remained significantly associated with risk of type 1 diabetes
after adjustment for maternal gluten intake during pregnancy, the suggestive association with
maternal gluten intake in category 2 and 5 were blunted after adjustment for child’s gluten
intake (Table 2).
Additional analyses
Analyses of those with complete covariate data showed similar results as in the main analyses
(S3 Table). The overall pattern across subgroups for birth weight and child’s sex was consistent
with the main findings (S5 Fig). We found no association between maternal dietary fibre
intake or gluten intake from refined grains during pregnancy and risk of type 1 diabetes in the
child (S4 Table and S5 Table). In analyses with further adjustment for child coeliac disease,
our results were essentially unchanged (Table 2). However, since the HR for child’s gluten
intake was slightly attenuated, we performed another sensitivity analysis after excluding chil-
dren who were diagnosed with coeliac disease during follow-up. The HR remained similar
(aHR = 1.37, 95% CI 0.98–1.93, p = 0.07 per 10-g increase for childhood intake), adjusted as in
model 2, but it was no longer significant due to the reduction of type 1 diabetes cases. Includ-
ing children who have a mother with type 1 diabetes or celiac disease in the primary model
gave essentially unchanged results (S6 Table). Finally, we additionally adjusted for other types
of diabetes in the mother (type 2 diabetes or gestational diabetes obtained from the medical
birth registry of Norway) in the primary model, and the results were essentially unchanged
Gluten intake and type 1 diabetes
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003032 March 2, 2020 8 / 15
(HR 1.48, 95% CI 1.09–1.99, p = 0.01, per 10-g/day increase in the child’s gluten intake, and
HR 0.98, 95% CI 0.71–1.36, p = 0.91, per 10-g/day increase in the maternal gluten intake).
Discussion
In this study, with both maternal and child gluten intake as exposures, we found that the
child’s gluten intake at 18 months of age was associated with the risk of type 1 diabetes while
maternal gluten intake during pregnancy was not.
Table 2. Association between maternal gluten intake during pregnancy (n = 86,306) or the child’s intake at 18 months (n = 66,725) and the risk of type 1 diabetes in
the child.
Gluten intake Cases Incidence rate (per
100,000)


























<7.6 g/day 23 22.3 Ref. Ref. Ref. Ref.




0.01 1.71 (0.94–3.09) 0.08 1.65 (0.91–
3.00)
0.10




0.13 1.37 (0.79–2.37) 0.26 1.32 (0.76–
2.30)
0.32




0.18 1.23 (0.67–2.26) 0.51 1.20 (0.65–
2.20)
0.56




0.04 1.50 (0.75–2.98) 0.25 1.41 (0.71–
2.82)
0.33




0.23 1.60 (0.75–3.39) 0.22 1.56 (0.73–
3.33)
0.24
ptrend 0.43 0.45 0.53 0.55
Child/18 months of life
Continuous, per 10-g/
day increase








<4.8 g/day 19 26.3 Ref. Ref. Ref. Ref.




0.37 1.30 (0.71–2.40) 0.39 1.37 (0.73–
2.56)
0.32




0.26 1.33 (0.80–2.23) 0.27 1.40 (0.82–
2.37)
0.22




0.41 1.24 (0.74–2.09) 0.42 1.24 (0.73–
2.11)
0.43




0.12 1.61 (0.89–2.91) 0.11 1.58 (0.87–
2.89)
0.14




0.04 1.86 (1.05–3.30) 0.03 1.86 (1.04–
3.34)
0.04
ptrend 0.05 0.05 0.04 0.07
�Model 1 (as in Antvorskov and colleagues [14]): adjusted for maternal age, prepregnant maternal BMI, parity, smoking during pregnancy, education, cesarean section,
breastfeeding, sex, and energy intake.
†Model 2 (primary model): as model 1 with additional adjustment for birth weight, age at gluten introduction, prematurity, fibre intake, weight gain 0–12 months, and
child’s or mother’s gluten intake (mutually adjusted exposures).
‡Model 3: as model 2 with additional adjustment for child coeliac disease.
Abbreviations: BMI, body mass index; CI, confidence interval; HR, hazard ratio; Ref., Reference category
https://doi.org/10.1371/journal.pmed.1003032.t002
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Comparison with previous studies
Our results on the mother’s intake of gluten during pregnancy are not in line with those from
the only previous study to assess this [14], despite remarkable similarities in characteristics,
maternal gluten intake, and methodology. A possible explanation for the discrepancy could be
that we were able to exclude participants based on maternal coeliac disease, while the other
study neither excluded nor adjusted for this in their analyses. Two studies of high-risk children
that investigated maternal intake of gluten-containing foods in pregnancy and development of
islet autoimmunity reported no significant association [12, 13]. Of note, both the exposure
(intake of gluten-containing cereals rather than amount of gluten) and outcome was different
from our study, and the number of children with outcome was small in these high-risk
cohorts. A recent study of high-risk children found that an increased gluten intake in child-
hood was associated with islet autoimmunity but not with type 1 diabetes [28], while another
study of high-risk children found no significant association between the child’s gluten intake
and islet autoimmunity or progression from islet autoimmunity to type 1 diabetes [29]. Again,
the apparent inconsistency may have been due to studies investigating different outcomes
(clinical type 1 diabetes versus progression) in different populations or due to lack of power.
Our results are probably generalizable to other industrialised countries but may not be applica-
ble to populations of non-European origin. In a recently published study from The Environ-
mental Determinants of Diabetes in the Young (TEDDY), a higher gluten intake during the
first 5 years of life was associated with increased risk of coeliac disease autoimmunity and coe-
liac disease among genetically predisposed children [30]. In another cohort of at-risk children,
gluten intake between the ages of 1 and 2 years—and, to a lesser extent, the cumulative intake
throughout childhood—were associated with the appearance of coeliac disease autoimmunity
and coeliac disease [31]. We have previously reported that an increased gluten intake at 18
months was associated with a modestly increased risk of coeliac disease in children from
MoBa [32].
Strengths and weaknesses
The prospective design with recruitment in pregnancy, large sample size, and linkage to
national registries with high levels of ascertainment are the strongest advantages of the study.
Missing data on child’s gluten intake at 18 months of age was mainly due to loss of follow-up,
which occurs in all cohorts that are based on voluntary participation. Having no significant
difference in risk of type 1 diabetes in those without complete data suggests that missing-data
bias was not a serious weakness. Furthermore, multiple imputation analyses have further con-
tributed to minimising any influence of bias due to missing data [27].
The recently published Danish national prospective cohort study has been criticised for not
including other dietary components related to gluten intake [33]. We included data on mater-
nal dietary fibre intake and gluten intake from refined grains during pregnancy. We also
adjusted for age at gluten introduction and infant weight gain [34]. We are not able to explore
all aspects of food intake; however, no dietary factors are established as a risk factor for type 1
diabetes [35]. We accounted for coeliac disease, both by excluding children of mothers with
coeliac disease from the analyses and adjusting for child coeliac disease.
Observational studies cannot exclude the possibility of unmeasured, unknown confounders
that could have influenced the results. Yet no environmental aetiological factors are clear, plau-
sible confounders.
We assessed gluten intake prospectively, but imprecisions in the estimations are likely, and
we only had information regarding gluten intake for the mother in the first half of pregnancy
and for the child at 18 months of age and no other time points in early life. We used
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questionnaires, which are suitable for estimating regular diet consumed over time but are not
as precise as other dietary assessment methods such as a dietary recall or records covering
shorter time periods—which, again, do not detect foods consumed outside the time of data
registration. The estimated intake of gluten was comparable to what has been reported in stud-
ies using the same or other dietary assessment methods, both for adults [14] and children [36–
39]. It is unlikely that imprecisions in gluten intake assessment from questionnaires is influ-
enced by future type 1 diabetes. Any bias is nondifferential when we have accounted for coeliac
disease in the child and in the mother. The large majority of type 1 diabetes cases were diag-
nosed long after 18 months, with the potential for reverse causation likely small. We did not
have prediagnostic data on islet autoantibodies and are therefore not able to provide informa-
tion on whether the associations with gluten intake are related to risk of islet autoimmunity or
progression from islet autoimmunity to type 1 diabetes. Another limitation is the lack of
genetic susceptibility variants. However, while these genetic variants obviously predict type 1
diabetes in the child, it is not obvious that they will confound the associations between mater-
nal or child’s gluten intake and type 1 diabetes by influencing also gluten intake, independently
of coeliac disease. We did not have detailed information on different ethnicities, but MoBa pri-
marily consists of ethnic Norwegians.
Self-selection in recruitment and losses to follow-up could lead to a nonrepresentative sam-
ple in the analyses. Those consenting to participate, and those continuing to participate in
MoBa, differ from the average population of women giving birth in Norway, in that the partici-
pants have high maternal age and education and there is a low proportion of daily smokers
among them [40]. Selection has been shown to play a minor role in association studies in
MoBa [40]. Adjusting for maternal education, age, and smoking during pregnancy did not
change our results substantially, suggesting that selection bias is unlikely to have had a major
influence on our findings.
Implications for research, clinical practice, and public policy
Our results show that, while the mother’s intake of gluten in pregnancy was not associated
with type 1 diabetes, a higher intake of gluten by the child at an early age may give a higher
risk. The results from a similar Danish national prospective cohort study [14] was not repli-
cated in our cohort, suggesting that there may not be causality. This may also be the case for
our finding of childhood intake of gluten as a possible risk factor for type 1 diabetes later in
life, which needs to be replicated in other large cohorts or intervention studies.
The child’s gluten intake at 18 months of age may possibly increase the risk of type 1 diabe-
tes through several mechanisms related to the immune system [3]. It has been shown that
increased gut permeability, which facilitates abnormal absorption of macromolecules, is asso-
ciated with type 1 diabetes and is detectable before clinical onset [41]. In a recently published
study from TEDDY, small changes in abundance of bacterial genera were found in cases with
type 1 diabetes compared to controls, such that controls had a higher abundance of bacterial
genera that might be indicative of enhanced gut integrity [42]. The child’s diet in early life is
more important for microbiota development in the child than maternal diet during pregnancy,
and our assessment of childhood intake of gluten was during the transitional phase of the
developing microbiome, before the stable phase that is observed after 30 months of age [42].
The median age at seroconversion to islet autoimmunity preceding type 1 diabetes is around
24 months of age [43].
If replicated in prospective studies, these findings may motivate further interventional stud-
ies of gluten amount in childhood and type 1 diabetes. The results from our study should not
lead to changing of recommendations or lead to unnecessary dietary changes among
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individuals to avoid type 1 diabetes. Ours and other published data to date should be inter-
preted cautiously, as there are currently few prospective studies in this field, with conflicting
results, and no randomised intervention studies.
Conclusion
In conclusion, a higher intake of gluten in the child’s diet at 18 months, but not in maternal
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21. van Overbeek FM, Uil-Dieterman IG, Mol IW, Köhler-Brands L, Heymans HS, Mulder CJ. The daily glu-
ten intake in relatives of patients with coeliac disease compared with that of the general Dutch popula-
tion. Eur J Gastroenterol Hepatol. 1997; 9(11):1097–9. https://doi.org/10.1097/00042737-199711000-
00013 PMID: 9431901
22. Gellrich C, Schieberle P, Weiser H. Biochemical characterization and quantification of the storage pro-
tein (secalin) types in rye flour. Cereal Chem. 2003(80):102–9.
23. Ellis HJ, Freedman AR, Ciclitira PJ. Detection and estimation of the barley prolamin content of beer and
malt to assess their suitability for patients with coeliac disease. Clin Chim Acta. 1990; 189(2):123–30.
https://doi.org/10.1016/0009-8981(90)90082-4 PMID: 2204500
24. Skrivarhaug T, Stene LC, Drivvoll AK, Strøm H, Joner G. Incidence of type 1 diabetes in Norway among
children aged 0–14 years between 1989 and 2012: has the incidence stopped rising? Results from the
Norwegian Childhood Diabetes Registry. Diabetologia. 2014; 57(1):57–62. https://doi.org/10.1007/
s00125-013-3090-y PMID: 24149838
25. Mårild K, Kahrs CR, Tapia G, Stene LC, Størdal K. Infections and risk of celiac disease in childhood: a
prospective nationwide cohort study. Am J Gastroenterol. 2015; 110(10):1475–84. https://doi.org/10.
1038/ajg.2015.287 PMID: 26346866
26. Størdal K, Haugen M, Brantsæter AL, Lundin KE, Stene LC. Association between maternal iron supple-
mentation during pregnancy and risk of celiac disease in children. Clin Gastroenterol Hepatol. 2014; 12
(4):624–31.e1-2. https://doi.org/10.1016/j.cgh.2013.09.061 PMID: 24112997
Gluten intake and type 1 diabetes
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003032 March 2, 2020 14 / 15
27. Cummings P. Missing data and multiple imputation. JAMA Pediatr. 2013; 167(7):656–61. https://doi.
org/10.1001/jamapediatrics.2013.1329 PMID: 23699969
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